Industry Developments

BMI View: Aspen Pharmacare's increased cooperation in the marketing and production of GlaxoSmithKline (GSK)'s drugs is completely in line with BMI's views about the partnership between... 2012-04-24

BMI View: In keeping with President Alassane Ouatarra's promise to prioritise primary healthcare provision following Côte d'Ivoire's civil war in 2011, new data show pharmaceutical... 2012-04-24

BMI View: The Botswana Vaccine Institute (BVI) is one of the few organisations in the world that already manufactures a vaccine for the Southern African Territories type 2 (SAT-2) strain... 2012-04-23

BMI View: It is in the interest of local and multinational drugmakers to assist African markets in the field of pharmacovigilance (PV). Unfortunately, while PV systems are important... 2012-04-20

News: The Medicines Control Council (MCC) in South Africa has been asked to consider the compassionate use of a novel drug - TMC207 - on urgent basis, reports Health-e. Health Minister... 2012-04-20

BMI Core View: Emerging markets will drive industry growth. The importance of emerging markets to large multinational drugmakers cannot be overstated and BMI's Pharmaceutical Expenditure... 2012-04-19

BMI View: Collaborations with multinational pharmaceutical companies for technological transfers have made local generic drugmakers able to compete for large government tenders. Since... 2012-04-18

BMI View: The better-regulated markets of the Gulf Cooperation Council (GCC), South Africa and Israel will remain the most rewarding and least risky for drugmakers operating in the... 2012-04-17

BMI View: We concur with UAE-based NMC Healthcare's strategy to enter other markets in the Middle East and North Africa, starting with Qatar and Saudi Arabia. These are the markets... 2012-04-17

BMI View: The Egyptian pharmaceutical companies that have seen their share prices outperform since the start of the Arab Spring are all linked to large international holding companies.... 2012-04-05